주식/증권
➡️ 중립
How S&P Drug Titan Pfizer Plans To Outdo Its Own $6 Billion Franchise
요약
The next-generation version of Pfizer's $6 billion pneumococcal vaccine franchise topped its predecessor in a midstage study.